Senior insider sale
See Remarks at NEUMORA THERAPEUTICS, INC. — senior position signals high conviction
$3.4K
1.98K shares
What this filing means
MILLIGAN MICHAEL LEE plans to sell 1.98K shares of NEUMORA THERAPEUTICS, INC. valued at approximately $3.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2025ACC: 0001964306-25-000080
Officer· See Remarks
Since Feb 2026
1.98K
Shares to sell
$3.4K
Approx. market value
1.98K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
2/14/2025
1.98KTotal acquired1.98K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/14/2025 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 1.98K | — |
| Total | 1.98K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.98K
Market value
$3.4K
2/18/2025
Total
Units
1.98K
Value
$3.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/18/2025 | 1.98K | $3.4K | NASDAQ | Planned |
| Total | 1.98K | $3.4K | ||